Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients
July 17, 2008
from PR Newswire
Summits Research Releases Comments on HD, WFC, SGP, CL, and SAF
July 15, 2008
from PR Newswire
Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
July 11, 2008
from PR Newswire
Zacks Analyst Blog Highlights: El Paso Corp., Akzo Nobel N.V., Schering-Plough Corp., Moneygram International, Inc. and PMC-Sierra, Inc.
July 09, 2008
from Business Wire News Releases
Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
July 08, 2008
Corifollitropin alfa meets primary endpoints in ENGAGE Trial Read More
from PR Newswire
Seven Summits Research Releases Comments on INTC, X, AET, VIP, and SGP
July 03, 2008
from PR Newswire
Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
July 02, 2008
from PR Newswire
Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
June 27, 2008
from PR Newswire
Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
June 24, 2008
from PR Newswire
Keller Rohrback L.L.P. Announces ERISA Investigation of Schering-Plough Corporation 401K Plans
June 18, 2008
from GlobeNewswire News Releases
Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings
June 17, 2008
from PR Newswire
Zacks Analyst Blog Highlights: Metabasis Therapeutics Inc., Schering-Plough, ASM International, Applied Materials Inc. and Beacon Roofing Supply, Inc.
June 16, 2008
from Business Wire News Releases
Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
June 11, 2008
Study Demonstrated a Significant Reduction in the Signs and Symptoms of RA and Improved Physical Function Read More
from PR Newswire
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
June 11, 2008
Patients Receiving Every Four-Week Subcutaneous Golimumab Also Experienced Improvements in Physical Function and Disease Activity Read More
from PR Newswire
Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
June 10, 2008
Lawsuit claims manufacturers misled consumers about the use of Zetia and Vytorin. Read More
from PR Newswire
Schering-Plough's Sugammadex Provides Fast Reversal of Effects of Muscle Relaxants Used in General Anesthesia
June 02, 2008
Data Presented at European Society of Anesthesiology Show Potential of Novel Investigational Agent to Change Practice of Anesthesiology Read More
from PR Newswire
European Union's CHMP Issues Positive Opinion on Sugammadex
June 02, 2008
Anesthesiologists to have new tool that works within minutes, upon European approval Read More
from PR Newswire
About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO
May 30, 2008
from PR Newswire
Wall Street News Alert: TORO Is Wednesday's Stock to Watch! May 28, 2008
May 28, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Seven Summits Research Releases Alerts on MSFT, V, POT, SGP, and HSY
May 28, 2008
from PR Newswire
Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
May 27, 2008
from PR Newswire
Schering-Plough Elects Tessa Hilado Vice President and Treasurer
May 21, 2008
from PR Newswire
Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
May 21, 2008
from PR Newswire
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
May 15, 2008
from PR Newswire
Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
May 09, 2008
from PR Newswire
Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
May 08, 2008
Efficacy and safety data support potential of asenapine in the treatment of schizophrenia and bipolar I disorder Read More
from PR Newswire
Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
April 30, 2008
First batch of bluetongue Bovilis BTV8 vaccine released to supply Northern European countries Read More
from PR Newswire
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
April 30, 2008
from PR Newswire
Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
April 26, 2008
from PR Newswire
Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast
April 25, 2008
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here